Merck Announces Second-Quarter 2023 Financial Results

Go back to Merck Announces Second-Quarter 2023 Financial Results

Merck (MRK) Tops Q2 EPS by 12c; Raises Guidance

August 1, 2023 6:33 AM EDT

Merck (NYSE: MRK) reported Q2 EPS of ($2.06), $0.12 better than the analyst estimate of ($2.18). Revenue for the quarter came in at $15 billion versus the consensus estimate of $14.43 billion.

GUIDANCE:

Merck sees FY2023 EPS of $2.95-$3.05, versus the consensus of $2.60. Merck sees... More